Carl Wild

Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.

Carl Wild, D C Shugars, Teresa Greenwell et al. · Proceedings of the National Academy of Sciences · 1994 · 932 citations · Full text

Capture of an early fusion-active conformation of HIV-1 gp41

Rika A. Furuta, Carl Wild, Yongkai Weng et al. · Nature Structural Biology · 1998 · 495 citations

Protein Folding, Human Retrovirus, Antiviral Response +6

A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.

Carl Wild, Terrence G. Oas, Charlene McDanal et al. · Proceedings of the National Academy of Sciences · 1992 · 486 citations · Full text

Immunology, Molecular Biology, Synthetic Peptide Inhibitor +23

PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing

Feng Li, Ritu Goila-Gaur, Karl Salzwedel et al. · Proceedings of the National Academy of Sciences · 2003 · 426 citations · Full text

The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region

Susan W. Barnett, Shan Lu, I Srivastava et al. · Journal of Virology · 2001 · 218 citations · Full text

Immunology, Viral Pathogenesis, Viral Structural Protein +16